Plant ID: NPO1903
Plant Latin Name: Cyperus haspan
Taxonomy Genus: Cyperus
Taxonomy Family: Cyperaceae
NCBI TaxonomyDB:
1077496
Plant-of-the-World-Online:
304701-1
Unknown.
Brazil; Madagascar; Bangladesh; Kenya; Sudan; Guinea; Mali; Costa Rica; Cambodia; Malawi; Ethiopia; Tanzania; Somalia; Peru; Laos; Nigeria; Bolivia; Cameroon; Cote d'Ivoire; Ecuador; Benin; Ghana; Australia; Iran; Cuba; Togo; Venezuela; Zambia; Japan; Papua New Guinea; Burkina Faso; Sri Lanka; Guatemala; Zimbabwe; China; Suriname; Thailand; Dominican Republic; Belize; Sierra Leone; Liberia; Georgia; Uganda; Pakistan; Gambia; Philippines; Indonesia; New Caledonia; United States; Paraguay; Mauritania; Vietnam; French Guiana; Guinea-Bissau; Guyana; Honduras; Nepal; Taiwan; Jamaica; Seychelles; Angola; Myanmar; Chad; Equatorial Guinea; Nicaragua; Mexico; India; Trinidad and Tobago; South Africa; Senegal; Congo; Mozambique; Colombia; Burundi; Gabon; Niger; Fiji; Comoros
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 9.986E-10 | 1.087E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.106E-08 | 4.580E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 1.472E-08 | 4.580E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0017144; drug metabolic process | 1.498E-08 | 4.580E-05 | ABCC1, AKR1B1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.472E-08 | 4.580E-05 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.178E-07 | 2.331E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.292E-07 | 2.344E-04 | AKR1B1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 3.216E-07 | 4.668E-04 | CYP1A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 1.500E-06 | 1.593E-03 | CYP1A1, CYP1A2 |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 1.585E-06 | 1.593E-03 | AKR1B1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0051186; cofactor metabolic process | 1.756E-06 | 1.593E-03 | ABCC1, AKR1B1, CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.815E-06 | 2.270E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0071280; cellular response to copper ion | 4.177E-06 | 3.136E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.510E-06 | 3.778E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 1.019E-05 | 6.343E-03 | ABCC1, AKR1B1, CYP1A1, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0035902; response to immobilization stress | 1.476E-05 | 8.929E-03 | CYP1A1, CYP1A2 |
MF | GO:0003824; catalytic activity | GO:0032451; demethylase activity | 3.957E-05 | 1.873E-02 | CYP1A1, CYP1A2 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.005E-03 | 1.863E-01 | CYP1A1, CYP1A2, CYP1B1 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 1.723E-02 | 1.000E+00 | AKR1B1 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 2.225E-02 | 1.000E+00 | CYP1A1, CYP1A2, CYP1B1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 7.391E-08 | 1.330E-06 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.305E-07 | 2.075E-06 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.641E-07 | 2.785E-06 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 6.604E-07 | 2.972E-06 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 6.096E-05 | 2.195E-04 | CYP1A1, CYP1B1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.034E-04 | 3.101E-04 | CYP1A2, CYP1A1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.158E-03 | 4.315E-03 | CYP1A2, CYP1A1, AKR1B1 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 2.134E-03 | 4.315E-03 | ABCC1, CYP1B1 |
09150 Organismal Systems | 09154 Digestive system | hsa04977 | Vitamin digestion and absorption | 5.986E-03 | 1.078E-02 | ABCC1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.250E-03 | 3.213E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|